Literature DB >> 32293840

Anatomic alterations across amygdala subnuclei in medication-free patients with obsessive-compulsive disorder.

Lianqing Zhang1, Xinyu Hu1, Lu Lu1, Bin Li1, Xiaoxiao Hu1, Xuan Bu1, Hailong Li1, Shi Tang1, Yingxue Gao1, Yanchun Yang1, John A Sweeney1, Qiyong Gong1, Xiaoqi Huang1.   

Abstract

Background: The amygdala has been implicated in obsessive-compulsive disorder (OCD), a common, disabling illness. However, the regional distribution of anatomic alterations in this structure and their association with the symptoms of OCD remains to be established.
Methods: We collected high-resolution 3D T1-weighted images from 81 untreated patients with OCD and no lifetime history of comorbid psychotic, affective or anxiety disorders, and from 95 age- and sex-matched healthy controls. We extracted the volume of the central nucleus of the amygdala (CeA) and the basolateral complex of the amygdala (BLA) and compared them across groups using FreeSurfer 6.0. In exploratory analyses, we evaluated other subnuclei, including the cortical medial nuclei, the anterior amygdaloid area, and the corticoamygdaloid transition area.
Results: Patients with OCD had reduced amygdala volume bilaterally compared with healthy controls (left, p = 0.034; right, p = 0.002). Volume reductions were greater in the CeA (left: -11.9%, p = 0.002; right: -13.3%, p < 0.001) than in the BLA (left lateral nucleus: -3.3%, p = 0.029; right lateral nucleus: -3.9%, p = 0.018; right basal nucleus: -4.1%, p = 0.017; left accessory basal nucleus: -6.5%, p = 0.001; right accessory basal nucleus: -9.3%, p < 0.001). Volume reductions in the CeA were associated with illness duration. Exploratory analysis revealed smaller medial (left: -15.4%, p < 0.001, η2 = 0.101) and cortical (left: -9.1%, p = 0.001, η2 = 0.058; right: -15.4%, p < 0.001, η2 = 0.175) nuclei in patients with OCD compared with healthy controls. Limitations: Although the strict exclusion criteria used in the study helped us to identify OCD-specific alterations, they may have limited generalizability to the broader OCD population.
Conclusion: Our results provide a comprehensive anatomic profile of alterations in the amygdala subnuclei in untreated patients with OCD and highlight a distinctive pattern of volume reductions across subnuclei in OCD. Based on the functional properties of the amygdala subnuclei established from preclinical research, CeA impairment may contribute to behavioural inflexibility, and BLA disruption may be responsible for altered fear conditioning and the affective components of OCD.
© 2020 Joule Inc. or its licensors.

Entities:  

Year:  2020        PMID: 32293840      PMCID: PMC7850150          DOI: 10.1503/jpn.190114

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  65 in total

1.  Encoding of conditioned fear in central amygdala inhibitory circuits.

Authors:  Stephane Ciocchi; Cyril Herry; François Grenier; Steffen B E Wolff; Johannes J Letzkus; Ioannis Vlachos; Ingrid Ehrlich; Rolf Sprengel; Karl Deisseroth; Michael B Stadler; Christian Müller; Andreas Lüthi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  A nonparametric method for automatic correction of intensity nonuniformity in MRI data.

Authors:  J G Sled; A P Zijdenbos; A C Evans
Journal:  IEEE Trans Med Imaging       Date:  1998-02       Impact factor: 10.048

3.  Olfactory identification and discrimination in obsessive-compulsive disorder.

Authors:  Cinto Segalàs; Javier Labad; Pino Alonso; Eva Real; Marta Subirà; Blanca Bueno; Susana Jiménez-Murcia; José M Menchón
Journal:  Depress Anxiety       Date:  2011-05-26       Impact factor: 6.505

Review 4.  The role of central and medial amygdala in normal and abnormal aggression: A review of classical approaches.

Authors:  Jozsef Haller
Journal:  Neurosci Biobehav Rev       Date:  2017-09-14       Impact factor: 8.989

5.  Symptoms of obsessive-compulsive disorder.

Authors:  J F Leckman; D E Grice; J Boardman; H Zhang; A Vitale; C Bondi; J Alsobrook; B S Peterson; D J Cohen; S A Rasmussen; W K Goodman; C J McDougle; D L Pauls
Journal:  Am J Psychiatry       Date:  1997-07       Impact factor: 18.112

6.  Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala.

Authors:  Daniel Huber; Pierre Veinante; Ron Stoop
Journal:  Science       Date:  2005-04-08       Impact factor: 47.728

7.  Amygdala circuitry mediating reversible and bidirectional control of anxiety.

Authors:  Kay M Tye; Rohit Prakash; Sung-Yon Kim; Lief E Fenno; Logan Grosenick; Hosniya Zarabi; Kimberly R Thompson; Viviana Gradinaru; Charu Ramakrishnan; Karl Deisseroth
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

8.  Amygdala activation in response to facial expressions in pediatric obsessive-compulsive disorder.

Authors:  Jennifer C Britton; S Evelyn Stewart; William D S Killgore; Isabelle M Rosso; Lauren M Price; Andrea L Gold; Daniel S Pine; Sabine Wilhelm; Michael A Jenike; Scott L Rauch
Journal:  Depress Anxiety       Date:  2010-07       Impact factor: 6.505

9.  Highly accurate inverse consistent registration: a robust approach.

Authors:  Martin Reuter; H Diana Rosas; Bruce Fischl
Journal:  Neuroimage       Date:  2010-07-14       Impact factor: 6.556

10.  Consolidation of altered associability information by amygdala central nucleus.

Authors:  Felipe L Schiffino; Peter C Holland
Journal:  Neurobiol Learn Mem       Date:  2016-07-15       Impact factor: 2.877

View more
  2 in total

1.  Amygdala subnuclei volumes and anxiety behaviors in children and adolescents with autism spectrum disorder, attention deficit hyperactivity disorder, and obsessive-compulsive disorder.

Authors:  Diane Seguin; Sara Pac; Jianan Wang; Rob Nicolson; Julio Martinez-Trujillo; Evdokia Anagnostou; Jason P Lerch; Christopher Hammill; Russell Schachar; Jennifer Crosbie; Elizabeth Kelley; Muhammad Ayub; Jessica Brian; Xudong Liu; Paul D Arnold; Stelios Georgiades; Emma G Duerden
Journal:  Hum Brain Mapp       Date:  2022-07-12       Impact factor: 5.399

2.  Amygdala subnuclear volumes in temporal lobe epilepsy with hippocampal sclerosis and in non-lesional patients.

Authors:  Alice Ballerini; Manuela Tondelli; Francesca Talami; Maria Angela Molinari; Elisa Micalizzi; Giada Giovannini; Giulia Turchi; Marcella Malagoli; Maurilio Genovese; Stefano Meletti; Anna Elisabetta Vaudano
Journal:  Brain Commun       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.